Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  Divi's Laboratories Limited    DIVISLAB   INE361B01024

DIVI'S LABORATORIES LIMITED

(DIVISLAB)
  Report  
End-of-day quote. End-of-day quote NATIONAL STOCK EXCHANGE OF INDIA - 11/15
1747.7 INR   +5.51%
08/14DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
FA
2018DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
FA
2017DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
FA
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
11/08/2019 11/11/2019 11/13/2019 11/14/2019 11/15/2019 Date
1699.95(c) 1710.55(c) 1672.5(c) 1656.5(c) 1747.7 Last
469 867 207 500 878 362 892 696 2 475 371 Volume
-1.05% +0.62% -2.22% -0.96% +5.51% Change
More quotes
Financials (INR)
Sales 2020 55 323 M
EBIT 2020 17 477 M
Net income 2020 14 000 M
Finance 2020 87,6 M
Yield 2020 0,81%
Sales 2021 64 039 M
EBIT 2021 21 423 M
Net income 2021 17 363 M
Finance 2021 1 226 M
Yield 2021 0,93%
P/E ratio 2020 33,3x
P/E ratio 2021 26,9x
EV / Sales2020 8,38x
EV / Sales2021 7,23x
Capitalization 464 B
More Financials
Company
Divi's Laboratories Limited is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs) and Intermediates. The Company's geographical segments include India (Sales to customers within India) and other countries (Sales to customers outside India). Its products include Generic... 
Sector
Pharmaceuticals
Calendar
02/05Earnings Release
More about the company
Surperformance© ratings of Divi's Laboratories Limite
Trading Rating : Investor Rating :
More Ratings
Latest news on DIVI'S LABORATORIES LIMITE
08/14DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
FA
2018DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
FA
2017DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
FA
2016DIVI'S LABORATORIES LTD : Ex-dividend day for interim dividend
FA
2015DIVI'S LABORATORIES LTD : BONUS ISSUE: 1 new share for 1 existing share
FA
2015DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
FA
2014DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
FA
2013DIVI'S LABORATORIES LTD : Press Release Qtr 1 2013-14
PU
2013DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
FA
2013DIVI'S LABORATORIES LIMITED : Press Release Qtr 4 2012-13.
PU
2013DIVI'S LABORATORIES LIMITED : Press Release Qtr 3 2012-13.
PU
2012DIVI'S LABORATORIES LIMITED : Ex-dividend day for final dividend
FA
2011DIVI'S LABORATORIES LIMITED : Divi’s Labs earns an Income of Rs.366 crores in Q2..
PU
More news
News in other languages on DIVI'S LABORATORIES LIMITE
08/14DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
2018DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
2017DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
2016DIVI'S LABORATORIES LTD : Ex-dividend day for interim dividend
2015DIVI'S LABORATORIES LTD : BONUS ISSUE: 1 new share for 1 existing share
More news
Sector news : Generic Pharmaceuticals
05:45aJ&J Rapidly Tested Its Baby Powder After Asbestos Finding -- and the Results ..
DJ
11/16Johnson & Johnson Opioid Verdict Cut -- WSJ
DJ
11/15FTC Requires Bristol-Meyers Squibb, Celgene to Divest Otezla as Condition of ..
DJ
11/15Johnson & Johnson's Oklahoma Opioid Penalty Reduced to $465 Million
DJ
11/15NOVARTIS : FDA Approves Novartis' Adakveo for Some Patients with Sickle Cell Com..
DJ
More sector news : Generic Pharmaceuticals
Chart DIVI'S LABORATORIES LIMITED
Duration : Period :
Divi's Laboratories Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DIVI'S LABORATORIES LIMITE
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 1 800,50  INR
Last Close Price 1 747,70  INR
Spread / Highest target 14,4%
Spread / Average Target 3,02%
Spread / Lowest Target -8,45%
EPS Revisions
Managers
NameTitle
Murali Krishna P. Divi Chairman & Managing Director
L. Kishore Babu Chief Financial Officer
L. Ramesh Babu Chief Information Officer & VP-Procurement
Ramesh Babu M. General Manager-Technical Operations
Srinivasa Rao P. General Manager-Technical Operations
Sector and Competitors